GL1X · GenesisL1 explorer

Research workbench

HIV integrase core domain (in) in complex with dimer-spanning ligand

Analyse HIV integrase core domain (in) in complex with dimer-spanning ligand in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7L1P
Type
protein
Length
274 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrase
EC
2.7.-.-
UniProt
Q76353
Ligands
R2A, SO4, IOD
Pockets
3 · best druggability 0.65

Structure

x-ray diffraction · 2 distinct chains · 52% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIntegrase (EC 2.7.-.-)protein13651% helix, 23% strandQ76353
BIntegrase (EC 2.7.-.-)protein13852% helix, 22% strandQ76353

Ligands and binding sites

  • R2A · (2-{[3-(4-{2-[(3-{[3-(carboxymethyl)-5-methyl-1-benzofuran-2-yl]ethynyl}benzene-1-carbonyl) amino]ethyl}piperazine-1-carbonyl)phenyl]ethynyl}-5-methyl-1-benzofuran-3-yl)acetic acid · ligand · chains A, B
  • SO4 · Sulfate ion · ion · 7 copies · chains A, B
  • IOD · Iodide ion · ion · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13290.650.8054R2A
2960.450.7916empty
31220.450.7722empty

Interfaces

1 interface between chains.

  • A–B · 1515 Ų buried · 20 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (oxidation).

Compared structures

  • 7L1P · HIV Integrase Core domain (IN) in complex with dimer-spanning ligand · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.